2016 AAPS National Biotechnology Conference
Event details
| Website: | |
| Location: | Sheraton Boston Hotel, 39 Dalton St., Boston, MA 02199, United States, America |
About
Sessions in four themes examine science from multiple perspectives:
- Biomarkers
- Formulation and Manufacturing
- Drug Delivery
- Immunogenicity
Take a look for the best pick of what’s on this year, and see what Bioanalysis Zone will be up to.
Activities and highlights for this year’s meeting
Booths
 Stop by booth #438 to see our exhibit or to meet with one of our attending scientific staff. |
 Q2 Solutions will be attending this year’s AAPS-NBC conference, and will be located at booth #135. Please visit our poster T2087 – Fit for Purpose Development and Validation of a Urea Biomarker Assay to Support Pre-clinical Studies during the Tuesday Contributed Paper Posters session 10:00 AM–4:30 PM May 17, 2016, Hall D. We look forward to seeing you in Boston! |
 Join us at booth #429 or our seminar at AAPS NBC to learn how SCIEX can help you address your challenges in biologics development. |
 Frustrated with a difficult biomarker or large molecule PK or ADA? This case study Biomarker for Phase III Clinical Trial illustrates how KCAS tackled a challenging project. Stop by booth #325 at AAPS-NBC to discuss how we might be able to help. |
Presentations
Setting the Bar and Establishing In-Study Cut-Points for Immunogenicity Testing Moderator: Kelly Colletti, Program Director of Bioanalytical Services, Charles River Monday, May 16th, 7:00 – 8:00 a.m. |
Everything Biologics—from Bioanalytical Quantification to Product Characterization: New Solutions for New Challenges Novel analytical tools are required to meet today’s challenges in biologics development. Combining technology innovations with smart data processing, SCIEX has developed unique MS workflows that enable sensitive detection and comprehensive characterization of complex biologics. The first part of the seminar will focus on Biologics Bioanalysis, with the second part being focused on Biologics Characterization. Date: Tuesday, May 17 Time: 1:00-5:00 PM Location: Gardener AB, 3rd floor of the Sheraton Boston Hotel |
Posters
| Development and Qualification of a Mass Spectrometric Immunoassay for Identification and Quantification of Wild-Type and Mutant Transthyretin in Human Serum Hua Wang, Research Chemist, WIL Research, a Charles River company |
Analytical and Formulation Considerations for the Development of a Multi-component IV Formulation Shiladitya Sen, Research Chemist, WIL Research, a Charles River company |
The Correlation of an Anti-PEG Antibody Assay Results with Allergic Reactions Valerie Leesch, Associate Scientific Director, Bioanalytical Sciences, WIL Research, a Charles River company |
T2087 – Fit for Purpose Development and Validation of a Urea Biomarker Assay to Support Pre-clinical Studies Tuesday Contributed Paper Posters session 10:00 AM–4:30 PM May 17, 2016, Hall D |
 Ultrasensitive Multiparameter Biomarker Quantification in Microsampling Support Christiam Pieper, Beena Punnamoottil, Michael Adler, Hendrick Schroeder, MarkSpengler Chimera Biotec GmbH |
White Papers
- Bioanalytical Support in the Development of Biologics
The Need for Sensitivity Combined with Broad Assay Range – Case Studies
Dr. Christian Pieper Chimera Biotec GmbH - 2015 White Paper on recent issues in bioanalysis: focus on new technologies and biomarkers (Part 2 – hybrid LBA/LCMS and input from regulatory agencies)
This White Paper (part 2 of 3) from the 2015 9th Workshop on Recent Issues in Bioanalysis (WRIB) covers the recommendations for hybrid LBA/LCMS and regulatory agencies’ inputs. - 2015 White Paper on recent issues in bioanalysis: focus on new technologies and biomarkers (Part 3 – LBA, biomarkers and immunogenicity)
This White Paper (part 3 of 3) from the 2015 9th Workshop on Recent Issues in Bioanalysis (WRIB) covers the recommendations for hybrid LBA/LCMS and regulatory agencies’ inputs. - 2013 White Paper on recent issues in bioanalysis: ‘hybrid’ – the best of LBA and LCMS
This White Paper focuses on the discussions, consensus and resulting recommendations on 16 recent issues (‘hot’ topics) in bioanalysis.
Bioanalysis reading highlights
- Hybridizing LBA with LC–MS/MS: the new norm for biologics quantification
- Interview with Nico van de Merbel (PRA Health Sciences) on the regulatory challenges faced by bioanalytical laboratories and developments in the relationships between LBA and LC-MS scientists
- Fundamentals of large-molecule protein therapeutic bioanalysis using ligand-binding assays
- Matrix effect in ligand-binding assay: the importance of evaluating emerging technologies
- The ‘blended’ bioanalytical laboratory: the marriage of antibody- and instrument-based methods and expertise
What is Bioanalysis doing?
Firstly, you’re most likely already a valued Bioanalysis subscriber, but if not we’re offering you a free company-wide trial to the journal.
Already subscribe to Bioanalysis? We also publish Biomarkers in Medicine, Immunotherapy and Future Oncology. So if you would like to gain access to these journals stop by and request a trial.
Finally, we will be presenting the much anticipated infographic results of our latest Spotlight on Large molecule analysis by LC-MS, as well as offering you the chance to complete our current survey on Hybrid LBA/LC-MS.
And the best news is – everyone who registers for a trial or completes our survey is entered into a draw to win a luxury Fortnum and Mason Hamper!
The Bioanalysis team will be at booth #136 at the AAPS and will be happy to meet you:
Sarah Bishop is available to answer all your advertising and sponsorship enquiries.
Dominik March can answer any access to content questions for the Bioanalysis journal